{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T15:16:40Z","timestamp":1771082200912,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T00:00:00Z","timestamp":1517270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jsps.2018.01.012","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T14:39:23Z","timestamp":1517495963000},"page":"306-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies"],"prefix":"10.1007","volume":"26","author":[{"given":"Amneh","family":"Al-Husseini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rana","family":"Abu-Farha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayyada","family":"Wazaify","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Claire","family":"Van Hout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.jsps.2018.01.012_b0005","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.3109\/10826080802490683","article-title":"Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan","volume":"45","author":"Albsoul-Younes","year":"2010","journal-title":"Subs. Use Misuse"},{"key":"10.1016\/j.jsps.2018.01.012_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00228-013-1594-5","article-title":"factors associated with pregabalin dispensing at higher than the approved maximum dose","volume":"70","author":"Bod\u00e9n","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2018.01.012_b0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s40261-016-0421-z","article-title":"Disproportionality analysis for the assessment of abuse and dependence potential of pregabalin in the French pharmacovigilance database","volume":"36","author":"Bossard","year":"2016","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.jsps.2018.01.012_b0020","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 Annual report of the american association of poison control centers' national poison data system (NPDS): 28th annual report","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin. Toxicol. (Phila)"},{"key":"10.1016\/j.jsps.2018.01.012_b0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000337028","article-title":"Misuse of medicines in the European union: a systematic review of the literature","volume":"18","author":"Casati","year":"2012","journal-title":"Euro. Addict. Res."},{"key":"10.1016\/j.jsps.2018.01.012_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1526-4637.2006.00259.x","article-title":"The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS)","volume":"8","author":"Cicero","year":"2007","journal-title":"Pain Med."},{"key":"10.1016\/j.jsps.2018.01.012_b0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/14659891.2011.615002","article-title":"Over-the-counter medicine abuse\u2013a review of the literature","volume":"18","author":"Cooper","year":"2013","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.jsps.2018.01.012_b0040","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00228-012-1464-6","article-title":"Pregabalin abuse and dependence in Germany: results from a database query","volume":"69","author":"Gahr","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2018.01.012_b0045","unstructured":"JFDA. (2014). Jordan Food and Drug Administration. Formal Statement About the Restricted Dispensing of Pregabalin in Jordan. <http:\/\/www.jfda.jo\/EchoBusV3.0\/SystemAssets\/ce7e7f71-3158-4f56-92bd 5ea766cbce16.jpg>"},{"key":"10.1016\/j.jsps.2018.01.012_b0050","unstructured":"JFDA. (2017). Jordan Food and Drug Administration. Formal Statement About the Restricted Dispensing of Pregabalin in Jordan. <http:\/\/www.jfda.jo\/EchoBusV3.0\/SystemAssets\/2f00f42e-427b-40ba-abf4 93adfb8c2ad6.jpg>."},{"key":"10.1016\/j.jsps.2018.01.012_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2016.10.038","article-title":"Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States","volume":"170","author":"Kerridge","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jsps.2018.01.012_b0060","doi-asserted-by":"crossref","first-page":"g1290","DOI":"10.1136\/bmj.g1290","article-title":"Potential misuse of pregabalin and gabapentin","volume":"348","author":"Loftus","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jsps.2018.01.012_b0065","unstructured":"NIDA. (2014). National Institute on Drug Abuse. Commonly Abused Drugs Charts. Retrieved from <https:\/\/www.drugabuse.gov\/drugs-abuse\/commonly-abused-drugs>"},{"key":"10.1016\/j.jsps.2018.01.012_b0070","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.seizure.2006.02.004","article-title":"Pregabalin-associated acute psychosis and epileptiform EEG-changes","volume":"15","author":"Olaizola","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.jsps.2018.01.012_b0075","doi-asserted-by":"crossref","first-page":"709","DOI":"10.5414\/CP202118","article-title":"Pregabalin's abuse potential: a mini review focusing on the pharmacological profile","volume":"52","author":"Papazisis","year":"2014","journal-title":"Int. J. Clin. Pharmacol. Therap."},{"key":"10.1016\/j.jsps.2018.01.012_b0080","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-0042-101868","article-title":"Use of pregabalin\u2013a nationwide pharmacoepidemiological drug utilization study with focus on abuse potential","volume":"49","author":"Schjerning","year":"2016","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jsps.2018.01.012_b0085","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00228-010-0853-y","article-title":"A signal for an abuse liability for pregabalin\u2013results from the Swedish spontaneous adverse drug reaction reporting system","volume":"66","author":"Schwan","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jsps.2018.01.012_b0090","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1002\/jps.22161","article-title":"Package selection for moisture protection for solid, oral drug products","volume":"99","author":"Waterman","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jsps.2018.01.012_b0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/14659891.2016.1235734","article-title":"Jordanian community pharmacists\u2019 experience regarding prescription and nonprescription drug abuse and misuse in Jordan\u2013An update","volume":"22","author":"Wazaify","year":"2017","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.jsps.2018.01.012_b0100","first-page":"1","article-title":"Ophthalmic drops abuse in community pharmacy setting: a cross-sectional study from Jordan","author":"Wazaify","year":"2017","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.jsps.2018.01.012_b0105","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11096-007-9135-x","article-title":"Self-medication patterns in Amman, Jordan","volume":"30","author":"Yousef","year":"2008","journal-title":"Pharm. World Sci."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418300124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016418300124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:31:37Z","timestamp":1736184697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016418300124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1319016418300124"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2018.01.012","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregabalin dispensing patterns in Amman-Jordan: An observational study from community pharmacies","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2018.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}